Now that 2022 is behind us, Diabetes in Control presents our top 5 viewed articles from the year. Delve into this content to learn more about diabetes, its effects on individuals with the condition, and a revolutionary treatment breakthrough. #1 The impact of health coaching with family support on patient …

Recently, the United States Food and Drug Administration granted approval for Tzield (teplizumab-mzwv) injection: a groundbreaking treatment intended to obstruct the progression of stage 2 type 1 diabetes into its more serious form in adults as well as pediatric patients who are 8 years or older. John Sharretts, M.D., director …